hotspot -WSS

hotspot

author：fashion 2025-08-23 08:54:41 - browse：85

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： WuXi out of biotech trade group, U.S. and China relations to blame

WSS

The best solution to the drug shortages problem

Why failed clinical trials don’t always spell doom for a new drug

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Amid AI frenzy, a top HHS official's quest to create safeguards

For Cytokinetics, FDA rejection of heart drug would help, not hinder

HHS secretary Becerra pressed on Change HealthCare cyberattack

hotspot

hotspot

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

South Korea throws huge K

Drug repurposing or repositioning? The language matters

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Hollywood unions extend contract negotiations for actors

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

23andMe had bad news about my health. I wish a person had delivered it

NIH trials fail to test meaningful long Covid therapies, experts say

Malaria cases in Florida and Texas: Here’s what you need to know

The best solution to the drug shortages problem

entertainment

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

In same hospitals, Black patients receive fewer opioids than white patients

Methadone doses haven’t kept up in the age of fentanyl

Police still searching for prisoner who escaped from NYC hospital

Wegovy’s successful heart trial raises vital question about weight loss

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

leisure time

Wikipedia

focus

entertainment